BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $896,000 | -11.3% | 5,928 | -14.4% | 0.02% | -34.8% |
| Q2 2022 | $1,010,000 | +395.1% | 6,927 | +303.7% | 0.02% | +1050.0% |
| Q1 2022 | $204,000 | -40.7% | 1,716 | -31.4% | 0.00% | -66.7% |
| Q4 2021 | $344,000 | +29.3% | 2,503 | +30.6% | 0.01% | -14.3% |
| Q3 2021 | $266,000 | -50.4% | 1,917 | -65.3% | 0.01% | -50.0% |
| Q2 2021 | $536,000 | +84.8% | 5,520 | +30.1% | 0.01% | +180.0% |
| Q1 2021 | $290,000 | -43.9% | 4,242 | -29.8% | 0.01% | -68.8% |
| Q4 2020 | $517,000 | -35.8% | 6,039 | -51.2% | 0.02% | +77.8% |
| Q3 2020 | $805,000 | +173.8% | 12,378 | +207.9% | 0.01% | -25.0% |
| Q2 2020 | $294,000 | +1125.0% | 4,020 | +480.1% | 0.01% | +1100.0% |
| Q1 2020 | $24,000 | – | 693 | +17225.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 4 | -99.8% | 0.00% | -100.0% |
| Q3 2019 | $70,000 | +7.7% | 1,682 | +14.0% | 0.01% | +25.0% |
| Q2 2019 | $65,000 | -49.2% | 1,476 | -57.5% | 0.00% | -55.6% |
| Q4 2018 | $128,000 | -32.6% | 3,470 | -31.4% | 0.01% | -35.7% |
| Q3 2018 | $190,000 | +578.6% | 5,057 | +602.4% | 0.01% | +600.0% |
| Q2 2018 | $28,000 | 0.0% | 720 | -33.8% | 0.00% | 0.0% |
| Q1 2018 | $28,000 | -26.3% | 1,088 | +7.7% | 0.00% | -33.3% |
| Q3 2017 | $38,000 | -86.2% | 1,010 | -90.8% | 0.00% | -90.3% |
| Q2 2017 | $275,000 | – | 11,001 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |